1-((3s,5s,7s)-adamantan-1-yl)-3-benzylurea | 120615-86-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-((3s,5s,7s)-adamantan-1-yl)-3-benzylurea
• 英文别名: 1-(1-Adamantyl)-3-benzylurea
• CAS: 120615-86-3
• 化学式: C₁₈H₂₄N₂O
• mdl: MFCD01791110
• 分子量: 284.401
• InChiKey: MPIRFYYPSNNZEV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.611
• 拓扑面积：
  41.1
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  异氰酸1-金刚烷酯 、 苄胺 以 N,N-二甲基甲酰胺 为溶剂， 以100%的产率得到1-((3s,5s,7s)-adamantan-1-yl)-3-benzylurea
  参考文献：
  名称：

  Structure–activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase

  摘要：

  We explored both structure-activity relationships among substituted oxyoxalamides used as the primary pharmacophore of inhibitors of the human sEH and as a secondary pharmacophore to improve water solubility of inhibitors. When the oxyoxalamide function was modified with a variety of alkyls or substituted alkyls, compound 6 with a 2-adamantyl group and a benzyl group was found to be a potent sEH inhibitor, suggesting that the substituted oxyoxalamide function is a promising primary pharmacophore for the human sEH, and compound 6 can be a novel lead structure for the development of further improved oxyoxalamide or other related derivatives. In addition, introduction of substituted oxyoxalamide to inhibitors with an amide or urea primary pharmacophore produced significant improvements in inhibition potency and water solubility. In particular, the N,N,O-trimethyloxyoxalamide group in amide or urea inhibitors (26 and 31) was most effective among those tested for both inhibition and solubility. The results indicate that substituted oxyoxalamide function incorporated into amide or urea inhibitors is a useful secondary pharmacophore, and the resulting structures will be an important basis for the development of bioavailable sEH inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.12.027

文献信息

• Chemoselective isocyanide insertion into the N–H bond using iodine–DMSO: metal-free access to substituted ureas
  作者：Porag Bora、Ghanashyam Bez

  DOI：10.1039/c8cc05019h

  日期：——

  Insertion of isocyanides into the N–H bond gives access to many medicinally important and structurally diverse complex nitrogen-containing heterocycles. Although the transition metal catalyzed isocyanide insertion into the N–H bond is very common, polymerization of isocyanides in the presence of a transition metal and their strong coordination with metals are the common drawbacks. On the other hand

  将异氰酸酯插入到N–H键中可访问许多具有医学重要性且结构多样的复杂含氮杂环。尽管过渡金属催化的异氰酸酯插入到N–H键中非常普遍，但是在过渡金属存在下异氰酸酯的聚合以及它们与金属的强配位是常见的缺点。另一方面，在没有金属催化剂的情况下，大多数异氰酸酯对胺的惰性阻碍了将异氰酸酯插入胺中的无金属方法的发展。结果，只有少数几种金属催化方法具有有限的底物范围，可以用于通过尿素合成尿素。异氰酸酯插入胺中，尚无无金属的报道。有趣的是，文献中尚未报道将化学选择性异氰化物插入胺中。我们使用I 2 -DMSO试剂系统进行尿素的化学选择性合成，其中异氰酸酯仅与脂肪胺反应，而芳香胺则需要亲核活化剂（DABCO）来促进尿素的形成。通过避开常用但有毒的异氰酸酯，该方法可直接和化学选择性地接近尿素。
• KOBRAKOV, K. I.;AGRACHEVA, E. B.;XOXRINA, E. V.;SHVEXGEJMER, G. A., IZV. VUZOV XIMIYA I XIM. TEXNOL., 31,(1988) N 9, S. 41-44
  作者：KOBRAKOV, K. I.、AGRACHEVA, E. B.、XOXRINA, E. V.、SHVEXGEJMER, G. A.

  DOI：——

  日期：——
• Structure–activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase
  作者：In-Hae Kim、In-Hee Lee、Hisashi Nishiwaki、Bruce D. Hammock、Kosuke Nishi

  DOI：10.1016/j.bmc.2013.12.027

  日期：2014.2

  We explored both structure-activity relationships among substituted oxyoxalamides used as the primary pharmacophore of inhibitors of the human sEH and as a secondary pharmacophore to improve water solubility of inhibitors. When the oxyoxalamide function was modified with a variety of alkyls or substituted alkyls, compound 6 with a 2-adamantyl group and a benzyl group was found to be a potent sEH inhibitor, suggesting that the substituted oxyoxalamide function is a promising primary pharmacophore for the human sEH, and compound 6 can be a novel lead structure for the development of further improved oxyoxalamide or other related derivatives. In addition, introduction of substituted oxyoxalamide to inhibitors with an amide or urea primary pharmacophore produced significant improvements in inhibition potency and water solubility. In particular, the N,N,O-trimethyloxyoxalamide group in amide or urea inhibitors (26 and 31) was most effective among those tested for both inhibition and solubility. The results indicate that substituted oxyoxalamide function incorporated into amide or urea inhibitors is a useful secondary pharmacophore, and the resulting structures will be an important basis for the development of bioavailable sEH inhibitors. (C) 2013 Elsevier Ltd. All rights reserved.